The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Current and Emerging Products:In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.
Opportunities and Strategic Recommendations:Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.